Indivior Pharmaceuticals, Inc. (INDV): Total Liabilities
$1.30B
As of 2025-12-31
$1.44B
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.30B | -21.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.65B | -14.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $1.94B | n/a | 2026-02-26, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.30B | -21.3% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.61B | +2.5% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $336.81M | -26.0% |
| Alkermes plc. (ALKS) | 2025-12-31 | $667.70M | +13.1% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.12B | +3.8% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $656.90M | +128.2% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.03B | +25.6% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $3.10B | +10.7% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $899.65M | +5.1% |
Compare INDV, PBH, ACAD, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗